Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids

Journal of Clinical Epidemiology

Volumn 53, Issue 7, 2000, Pages 696-701

  Kennedy, Wendy A ^a,b   Laurier, Claudine ^a   Gautrin, Denyse ^a,b   Ghezzo, Heberto ^b   Paré, Michèle ^a   Malo, Jean Luc ^a,b   Contandriopoulos, André Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Ctr Quebecois d'Excellence S R   (Canada)

Author keywords

Bronchial diseases; Epidemiology; Inhaled steroid; Oral candidiasis

Indexed keywords

ANTIFUNGAL AGENT; STEROID;

AGED; ARTICLE; ASTHMA; BRONCHUS DISEASE; CANADA; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; THRUSH;

AGED; ANTIFUNGAL AGENTS; ASTHMA; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033866555     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00191-2     Document Type: Article

References (27)

1. Hargreave F., Dolovich J., Newhouse M. The assessment and treatment of asthma. a conference report J Allergy Clin Immunol. 85:1990;1098-1111.
2. Anonymous International Consensus Report on the Diagnosis and Management of Asthma. Clin Exper Allergy. 22:1992;1-72. (suppl. 1).
3. Podell R.N. National guidelines for the management of asthma in adults. Am Family Physician. 46:1992;1189-1196.
4. Ernst P, FitzGerald JM, Spier S. Canadian Consensus Conference on Asthma: Recommendations. Can Resp J 1996;3(2):101-14.
5. Guidelines on the management of asthma. Thorax. 48(suppl.):1993;1-s24.
6. Hudson L.D., Monti C.M. Rationale and use of corticosteroids in chronic obstructive pulmonary disease. Med Clin N Am. 74(3):1990;661-690.
7. Webster J.R., Kadah H. Unique aspects of respiratory disease in the aged. Geriatrics. 46(7):1991;31-43.
8. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 152:1995;S77-S120.
9. Kesten S., Rebuck A.S., Chapman K.R. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990. J Allergy Clin Immunol. 92(4):1993;499-506.
10. Habbick B., Baker M.J., McNutt M., Cockcroft D.W. Recent trends in the use of inhaled B2-adrenergic agonists and inhaled coriticosteroids in Saskatchewan. Can Med Assoc J. 153(10):1995;1437-1443.
11. Grant I.W., Crompton G.K., Milne L.J. Letter. Beclomethasone aerosol in chronic bronchial asthma Lancet. 2(7884):1974;838.
12. Milne L.J., Crompton G.K. Beclomethasone dipropionate and oropharyngeal candidiasis. BMJ. 3(5934):1974;797-798.
13. Willey R.F., Milne L.J., Crompton G.K., Grant I.W. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest. 70(1):1976;32-38.
14. Lovera J., Cooper D.M., Collins-Williams C., Levison H., Bailey J.D., Orange R.P. Clinical and physiological assessment of asthmatic children treated with beclomethasone dipropionate. J Allergy Clin Immunol. 57(2):1976;112-123.
15. Cayton RM, Soutar CA, Stanford CF, Turner GC, Nunn AJ. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 1974;(August 10):303-7.
16. Petri H., Kessels F., Kamakura T. Markers of adverse drug reactions in medication histories. An analysis of inhaled steroid utilization. Pharmaceutisch Weekblad Scientific Edition. 13(2):1991;97-106.
17. Toogood J.H., Lefcoe N.M., Haines D.S., Jennings B., Errington N., Baksh L., Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol. 59(4):1977;298-308.
18. Malo J.L., Cartier A., Ghezzo H., Trudeau C., Morris J., Jennings B. Comparison of four-times-a-day and twice-a-day dosing regimens in subjects requiring 1200 μg or less of budesonide to control mild to moderate symptoms. Resp Med. 89(7):1995;537-543.
19. Smith M.J., Hodson M.E. High-dose beclomethasone inhaler in the treatment of asthma. Lancet. 1(8319):1983;265-269.
20. Saltzman G.A., Pyzxczynski D.R. Oropharyngeal candidiasis in patients treated with beclomethasone diproprionate delivered by metered-dose inhaler alone and with aerochamber. J Allergy Clin Immunol. 81(2):1988;424-428.
21. Condemi J.J., Chervinsky P.C., Goldstein M.F., Ford L.B., Berger W.E., Ayars G.H., Rogenes P.R., Edwards L., Pepsin P.J. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma. J Allergy Clin Immunol. 100(4):1997;467-474.
22. Engel T., Heinig J.H., Malling H.J., Scharling B., Nikander K., Madsen F. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy. 44(3):1989;220-225.
23. ®. Allergy. 49(10):1994;888-890.
24. Toogood J.H., Baskerville J., Jennings B., Lefcoe N.M., Johansson S.A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Resp Dis. 129(5):1984;723-729.
25. Toogood J.H., Jennings B., Greenway R.W., Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol. 65(2):1980;145-153.
26. Tamblyn R., Lavoie G., Petrella L., Monette J. The use of prescription claims databases in pharmacoepidemiological research. The accuracy and comprehensiveness of the prescription claims database in Quebec J Clin Epidemiol. 48(8):1995;999-1009.
27. Mandell G.L., Douglas R.G., Bennett J.E. Principles and practice of infectious diseases. 3rd ed:1990;Churchill Livingston Inc, New York.